Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats (Q35932322)

11 August 2017

title

Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats (English)

1 reference

11 August 2017

Yueqiang Wen

1 reference

11 August 2017

Lingling Liu

1 reference

11 August 2017

Peilan Zhou

1 reference

11 August 2017

Huiyuan Li

1 reference

11 August 2017

Zebin Wang

1 reference

11 August 2017

Yajie Zhang

1 reference

11 August 2017

Jianbo Liang

1 reference

11 August 2017

publication date

24 February 2016

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

564-570

1 reference

Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

21 January 2018

The Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Cabin1 expression suggests roles in neuronal development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Influence of tacrolimus on podocyte injury inducted by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Calcineurin (CN) Activation Promotes Apoptosis of Glomerular Podocytes Both in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Cabin1 restrains p53 activity on chromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2016.1148936

10.3109/0886022X.2016.1148936

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference